Pearl River, NY, United States of America

Thomas Nittoli

This inventor holds 41 USPTO granted patents and 18 published patent applications, plus 1 CIPO patent and 12 EPO patents, primarily in Antibody Therapeutics. Top assignees: Regeneron Pharmaceuticals, Inc., Regeneran Pharmaceuticals, Inc.. Active years: 2016-2026.

USPTO Granted Patents = 41 (Patent Applications = 18)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 12 (Patent Applications = 20)

Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 175(Granted Patents)

Company Filing History:

40 out of 1,471

Regeneron Pharmaceuticals, Inc.

patents

1 out of 49

Regeneran Pharmaceuticals, Inc.

patents

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Bispecific Antigen Binding

Antibody-Drug Conjugates

Anti-MUC16

Anti-MET

Protein-Antiviral Compounds

Maytansinoid Derivatives

Anti-STEAP2

Anti-EGFRvIII

Diels-Alder Conjugation

Biologically Active Molecules

Therapeutic Uses

Macrolide Diastereomers

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12715881 - RIFAMYCIN ANALOGS AND ANTIBODY-DRUG CONJUGATES THEREOF (2026-08-25),

2. 12691182 - Maytansinoid derivatives, conjugates thereof, and methods of use (2026-07-28),

3. 12583939 - BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND HER2, AND METHODS OF USE THEREOF (2026-03-24),

4. 12570764 - Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind MUC16 and CD3, and uses thereof (2026-03-10),

5. 12564640 - PROTEIN-ANTIVIRAL COMPOUND CONJUGATES (2026-03-03),

6. 12545735 - ANTI-MET ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND MET, AND METHODS OF USE THEREOF (2026-02-10),

7. 12497460 - ANTI-MSR1 ANTIBODIES AND METHODS OF USE THEREOF (2025-12-16),

8. 12419963 - Diels-Alder conjugation methods (2025-09-23),

9. 12378258 - Biologically active molecules, conjugates thereof, and therapeutic uses (2025-08-05),

10. 12297207 - Maytansinoid derivatives, conjugates thereof, and methods of use (2025-05-13),

11. 11958910 - Bispecific antigen binding molecules that bind HER2, and methods of use thereof (2024-04-16),

12. 11866502 - Anti-FGFR2 antibodies and methods of use thereof (2024-01-09),

13. 11814428 - Anti-PTCRA antibody-drug conjugates and uses thereof (2023-11-14),

14. 11752214 - Protein-antiviral compound conjugates (2023-09-12),

15. 11701427 - Diels-alder conjugation methods (2023-07-18),

Title: The Innovative Journey of Thomas Nittoli

Introduction: Thomas Nittoli, a talented inventor hailing from Pearl River, NY, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Thomas Nittoli's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a cutting-edge medical device designed to improve patient outcomes in the healthcare industry.

Career Highlights: With over two decades of experience in the field of technology and innovation, Thomas Nittoli has a proven track record of developing innovative solutions that have had a lasting impact on various industries. His ability to think outside the box and his dedication to pushing the boundaries of what is possible have earned him recognition as a leading inventor in his field.

Collaborations: Throughout his career, Thomas Nittoli has collaborated with top research institutions, leading companies, and brilliant minds in the industry to bring his ideas to life. His collaborative spirit and passion for innovation have led to the successful development of groundbreaking technologies that have changed the way we live and work.

Conclusion: Thomas Nittoli's relentless pursuit of innovation and his commitment to pushing the boundaries of technology have solidified his reputation as a visionary inventor. His contributions to the world of technology continue to inspire and shape the future of innovation.